Note: Page numbers followed by f indicate figures; those followed by t indicate tables; and those followed by b indicate boxed material.
Adjuvant chemotherapy for borderline tumors, 198 for early ovarian carcinoma biological and molecular markers with, 152-154, 154t choice of agents for, 150, 150t, 151f for clear cell carcinoma, 151-152, 151f and definition of early cancer, 143-144, 144b duration of, 150-151, 151t efficacy of, 147-149, 148f, 148t, 149t importance of surgical staging for, 146-147, 147b, 149, 149t and natural history of untreated disease, 144-145,
145f, 145t vs. radiation therapy, 151, 152f recommendations on, 144b, 154, 155b and substaging, 143, 144b, 145, 146f, 146t for germ cell tumors, 215-216 for granulosa cell tumors, 202-205, 203f for Sertoli-Leydig cell tumors, 208 Adriamycin. See Doxorubicin (Adriamycin). Advanced ovarian carcinoma chemotherapy for, 156-159
equivalency of carboplatin and cisplatin for, 156-157 evolution of platinum and taxane agents for, 156 intraperitoneal, 155f, 158-159, 158f maintenance, 159 neoadjuvant, 159
new combinations and dose schedules for, 157-158, 158f recommendations on, 155f taxanes for, 157 surgery for, 109-127 diaphragm resection in, 117, 117f, 118f en bloc pelvic resection in, 113-117, 114f, 115f, 116f interval cytoreduction in, 122-123, 123t, 124f liver resection in, 118, 118f lymph node resection in, 121, 122f palliative, 125-127
predictors of optimal cytoreduction with, 121-122 principles of cytoreduction in, 109-111, 110f, 111f, 112f recurrent, 124-125, 125f second-look, 124, 125f splenectomy in, 119, 119f, 120f, 121f surgical principles for, 111-113 survival with, 156 Advanced-stage borderline tumors, 134-135, 135t, 198 Advanced-stage sex cord-stromal tumors, 200
African-American women, incidence of ovarian cancer in, 3, 3t
Age, as prognostic factor, 9-10 Allelic imbalance, in carcinogenesis, 25 Alpha-fetoprotein (AFP), in germ cell tumors, 213 Androblastomas. See Sertoli-Leydig cell tumors (SLCTs).
Annular tubules, sex cord tumors with, 208-209 Antiangiogenesis agents, for recurrent and resistant ovarian cancer, 175
Apolipoprotein E (ApoE) overexpression, in carcinogenesis, 25
Artificial neural network analysis (ANN), for screening, 95
Ascites, and secondary cytoreduction, 183 Ashkenazi Jewish population, BRCA mutations in, 5-7, 36, 41, 52
Autosomal dominant inheritance, 34-35, 35f
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.